Status:
COMPLETED
Neuromodulation to Facilitate the Effect of Ketamine
Lead Sponsor:
The Neuroscience Center, LLC
Conditions:
Depression
Chronic Pain
Eligibility:
All Genders
18+ years
Brief Summary
application of external neuromodulation along with ketamine infusion.
Detailed Description
apply TMS concurrent with ketamine infusion in order to increase the likliehood \& strength of therapeutic benefit
Eligibility Criteria
Inclusion
- chronically ill,
- treatment-resistant
Exclusion
- active psychosis
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT01816958
Start Date
January 1 2011
End Date
November 1 2012
Last Update
March 22 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Neuroscience Center
Deerfield, Illinois, United States, 60015